Surgery is not the first-line treatment option for patients with type<unk>  DM. β-Cell Replacement Therapy  is usually reserved for patients with either who have an indication for kidney transplantation and are poorly controlled with large glycemic excursions or in patients who already received a kidney transplant.
Diabetes mellitus type 1 surgery
Diabetes mellitus type 2 surgery
Hypoglycemia surgery
Gastric dumping syndrome surgery
Stomach cancer surgery
Diabetes mellitus surgery
Non-alcoholic fatty liver disease surgery
Celiac disease surgery